HUTCHMED (China) HMDCF
NASDAQ HMDCF
$2.16 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

HUTCHMED (China) (HMDCF) Non Operating Income (2018 - 2021)

HUTCHMED (China)'s (HMDCF) quarterly Non Operating Income came in at $3.0 million in Q2 2021, up 624.94% year-over-year from $413000.0 in Q2 2020, and up 921.84% quarter-over-quarter from $293000.0 in Q1 2021.

Analysis

HUTCHMED (China) (HMDCF) Non Operating Income (2018 - 2021) Analysis & Trends

HUTCHMED (China) (HMDCF) has reported Non Operating Income for 4 consecutive years, with $3.0 million the latest figure, recorded in Q2 2021.

  • On a quarterly basis, Non Operating Income rose 624.94% year-over-year to $3.0 million in Q2 2021; TTM through Jun 2021 was $4.9 million, a 54.37% increase from a year earlier, with the FY2025 full-year figure at $61.0 million, up 43.09% from the prior year.
  • Non Operating Income was $3.0 million for Q2 2021 at HUTCHMED (China), up from $293000.0 in the prior quarter.
  • Over five years, Non Operating Income peaked at $3.0 million in Q2 2021 and troughed at -$31000.0 in Q4 2019.
  • A 4-year average of $1.3 million and a median of $1.2 million in 2018 frame the typical range for Non Operating Income.
  • Across the five-year window, Non Operating Income tumbled 102.8% in 2019 and soared 624.94% in 2021, its largest moves.
  • Over 4 years, Non Operating Income stood at $1.1 million in 2018, then plunged by 102.8% to -$31000.0 in 2019, then jumped by 1432.26% to $413000.0 in 2020, then soared by 624.94% to $3.0 million in 2021.
  • The last three Non Operating Income figures came in at $3.0 million (Q2 2021), $293000.0 (Q1 2021), and $413000.0 (Q2 2020), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Amgen 212.93 Bn 198.94 Bn 7.24 Bn -73.00 Mn
2 Gilead Sciences 181.03 Bn 177.85 Bn 6.22 Bn 387.00 Mn
3 Vertex Pharmaceuticals 132.73 Bn 124.87 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 82.26 Bn 74.27 Bn 3.93 Bn 234.30 Mn
5 Argenx Se 61.30 Bn 56.11 Bn 1.37 Bn -
6 Moderna 54.88 Bn 49.75 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 34.05 Bn 30.74 Bn 992.69 Mn -53.64 Mn
8 Biogen 31.22 Bn 29.94 Bn 1.96 Bn -
9 Roivant Sciences 29.91 Bn 29.91 Bn 1.16 Mn -
10 HUTCHMED (China) 376.85 Mn 391.04 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 2.99 Mn
Mar 31, 2021 293,000.00
Jun 30, 2020 413,000.00
Mar 31, 2020 1.17 Mn
Dec 31, 2019 -31,000.00
Sep 30, 2019 1.60 Mn
Jun 30, 2019 2.57 Mn
Mar 31, 2019 1.14 Mn
Dec 31, 2018 1.11 Mn
Sep 30, 2018 1.69 Mn
Jun 30, 2018 2.04 Mn
Mar 31, 2018 1.15 Mn